Stay updated on Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record now displays details for the completed KEYNOTE-799 Phase 2 trial of pembrolizumab with chemotherapy and radiotherapy for Stage III non-small cell lung cancer, including its study plan, outcome measures, and participant criteria.
    Difference
    95%
    Check dated 2026-11-11T02:07:20.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer's ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-04T00:34:07.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A sitewide notice about NIH terminology changes was added above the ClinicalTrials.gov page, and the displayed site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:34:53.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:46:25.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Sponsor-related content and external data-sharing links were removed from the page, including Merck branding, IPD sharing URLs, and references to study documents.
    Difference
    20%
    Check dated 2026-09-23T00:36:39.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.7.0 is now shown on the page, replacing the previous Revision: v3.6.6. This indicates an updated page revision of the study details.
    Difference
    0.0%
    Check dated 2026-09-15T23:49:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.